TABLE 3.
Percentage and mean intensity of SAMHD1 expression in PBMCs
| Cell type | % of cells expressing SAMHD1 | Mean SAMHD1 intensity | Mean SAMHD1 intensity/cell |
|---|---|---|---|
| Uninfected control | |||
| CD3+ CD4+ | 64 ± 16 | 2,690 ± 243 | 0.2 |
| CD3+ CD8+ | 50 ± 19 | 2,274 ± 346 | 0.5 |
| CD14+ CD16− | 49 ± 9 | 3,837 ± 394 | 0.4 |
| CD14+ CD16− | 58 ± 11 | 5,068 ± 437 | 7.2 |
| CD14− CD16+ | 32 ± 6 | 3,236 ± 472 | 14.6 |
| HTLV-1-infected | |||
| CD3+ CD4+ | 69.9 ± 11 | 3,004 ± 342 | 0.1 |
| CD3+ CD8+ | 76 ± 4 | 2,604 ± 418 | 0.3 |
| CD14+ CD16− | 95 ± 2 | 4,840 ± 1,255 | 0.6 |
| CD14+ CD16− | 96 ± 2 | 6,417 ± 1,195 | 4.4 |
| CD14− CD16+ | 94 ± 2 | 5,165 ± 705 | 4.1 |